These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34161696)

  • 21. [Analysis of SLC35A2 gene variant in a child with congenital disorder of glycosylation type IIm].
    Li J; Wang W; Zhu Q; Sun J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Oct; 38(10):989-992. PubMed ID: 34625939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel ALG12 variants and hydronephrosis in siblings with impaired N-glycosylation.
    Hiraide T; Wada Y; Matsubayashi T; Kadoya M; Masunaga Y; Ohkubo Y; Nakashima M; Okamoto N; Ogata T; Saitsu H
    Brain Dev; 2021 Oct; 43(9):945-951. PubMed ID: 34092405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disorder of sex development associated with a novel homozygous nonsense mutation in COG6 expands the phenotypic spectrum of COG6-CDG.
    Lugli L; Bariola MC; Ferri L; Lucaccioni L; Bertucci E; Cattini U; Torcetta F; Morrone A; Iughetti L; Berardi A
    Am J Med Genet A; 2021 Apr; 185(4):1187-1194. PubMed ID: 33394555
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further delineation of COG8-CDG: A case with novel compound heterozygous mutations diagnosed by targeted exome sequencing.
    Yang A; Cho SY; Jang JH; Kim J; Kim SZ; Lee BH; Yoo HW; Jin DK
    Clin Chim Acta; 2017 Aug; 471():191-195. PubMed ID: 28619360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital disorders of glycosylation type IIb with MOGS mutations cause early infantile epileptic encephalopathy, dysmorphic features, and hepatic dysfunction.
    Anzai R; Tsuji M; Yamashita S; Wada Y; Okamoto N; Saitsu H; Matsumoto N; Goto T
    Brain Dev; 2021 Mar; 43(3):402-410. PubMed ID: 33261925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The second DDOST-CDG patient with lactose intolerance, developmental delay, and situs inversus totalis.
    Pi S; Gong J; Xiao W; Xiao B; Mao X; Long H
    J Hum Genet; 2022 Feb; 67(2):103-106. PubMed ID: 34462534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SLC35A2-CDG: Novel variant and review.
    Quelhas D; Correia J; Jaeken J; Azevedo L; Lopes-Marques M; Bandeira A; Keldermans L; Matthijs G; Sturiale L; Martins E
    Mol Genet Metab Rep; 2021 Mar; 26():100717. PubMed ID: 33552911
    [No Abstract]   [Full Text] [Related]  

  • 28. Congenital disorders of glycosylation.
    Jaeken J
    Handb Clin Neurol; 2013; 113():1737-43. PubMed ID: 23622397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DDOST-CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype.
    Elsharkawi I; Wongkittichote P; Daniel EJP; Starosta RT; Ueda K; Ng BG; Freeze HH; He M; Shinawi M
    J Inherit Metab Dis; 2023 Jan; 46(1):92-100. PubMed ID: 36214423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
    Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
    Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital disorders of glycosylation: The Saudi experience.
    Alsubhi S; Alhashem A; Faqeih E; Alfadhel M; Alfaifi A; Altuwaijri W; Alsahli S; Aldhalaan H; Alkuraya FS; Hundallah K; Mahmoud A; Alasmari A; Mutairi FA; Abduraouf H; AlRasheed L; Alshahwan S; Tabarki B
    Am J Med Genet A; 2017 Oct; 173(10):2614-2621. PubMed ID: 28742265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
    Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital disorders of glycosylation with defective fucosylation.
    Hüllen A; Falkenstein K; Weigel C; Huidekoper H; Naumann-Bartsch N; Spenger J; Feichtinger RG; Schaefers J; Frenz S; Kotlarz D; Momen T; Khoshnevisan R; Riedhammer KM; Santer R; Herget T; Rennings A; Lefeber DJ; Mayr JA; Thiel C; Wortmann SB
    J Inherit Metab Dis; 2021 Nov; 44(6):1441-1452. PubMed ID: 34389986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-phenotype correlation of congenital anomalies in multiple congenital anomalies hypotonia seizures syndrome (MCAHS1)/PIGN-related epilepsy.
    Fleming L; Lemmon M; Beck N; Johnson M; Mu W; Murdock D; Bodurtha J; Hoover-Fong J; Cohn R; Bosemani T; Barañano K; Hamosh A
    Am J Med Genet A; 2016 Jan; 170A(1):77-86. PubMed ID: 26394714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG.
    Alsharhan H; Ng BG; Daniel EJP; Friedman J; Pivnick EK; Al-Hashem A; Faqeih EA; Liu P; Engelhardt NM; Keller KN; Chen J; Mazzeo PA; ; Rosenfeld JA; Bamshad MJ; Nickerson DA; Raymond KM; Freeze HH; He M; Edmondson AC; Lam C
    J Inherit Metab Dis; 2021 Jul; 44(4):987-1000. PubMed ID: 33583022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four New Cases of SLC35A2-CDG With Novel Mutations and Clinical Features.
    Abuduxikuer K; Wang JS
    Front Genet; 2021; 12():658786. PubMed ID: 34122512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALG13-CDG in a male with seizures, normal cognitive development, and normal transferrin isoelectric focusing.
    Gadomski TE; Bolton M; Alfadhel M; Dvorak C; Ogunsakin OA; Nelson SL; Morava E
    Am J Med Genet A; 2017 Oct; 173(10):2772-2775. PubMed ID: 28777499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early onset epileptic and developmental encephalopathy and MOGS variants: a new diagnosis in the whole exome sequencing (WES) ERA : Report of a new patient and review of the literature.
    Teutonico F; Volpe C; Proto A; Costi I; Cavallari U; Doneda P; Iascone M; Sturiale L; Barone R; Martinelli S; Vignoli A
    Neurogenetics; 2024 Jul; 25(3):281-286. PubMed ID: 38498292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG.
    Paketci C; Edem P; Hiz S; Sonmezler E; Soydemir D; Sarikaya Uzan G; Oktay Y; O'Heir E; Beltran S; Laurie S; Töpf A; Lochmuller H; Horvath R; Yis U
    Brain Dev; 2020 Aug; 42(7):539-545. PubMed ID: 32389449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune dysfunction in MGAT2-CDG: A clinical report and review of the literature.
    Poskanzer SA; Schultz MJ; Turgeon CT; Vidal-Folch N; Liedtke K; Oglesbee D; Gavrilov DK; Tortorelli S; Matern D; Rinaldo P; Bennett JT; Thies JM; Chang IJ; Beck AE; Raymond K; Allenspach EJ; Lam C
    Am J Med Genet A; 2021 Jan; 185(1):213-218. PubMed ID: 33044030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.